These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 38020326)
1. Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium. Zari S Stem Cells Cloning; 2023; 16():77-89. PubMed ID: 38020326 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial. El-Dawla RE; Abdelhaleem M; Abdelhamed A Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290 [TBL] [Abstract][Full Text] [Related]
3. Recent modalities in treatment of telogen effluvium: Comparative study. Khattab FM; Rady A; Khashaba SA Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518 [TBL] [Abstract][Full Text] [Related]
4. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334 [TBL] [Abstract][Full Text] [Related]
5. The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment. Lee YI; Kim J; Kim J; Park S; Lee JH Dermatol Surg; 2020 Dec; 46(12):1698-1704. PubMed ID: 32769526 [TBL] [Abstract][Full Text] [Related]
6. Adipose-derived stem cell conditioned medium for hair regeneration therapy in alopecia: a review of literature. Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Fahira A; Ramadan ET; Paramastri K Arch Dermatol Res; 2024 Aug; 316(8):525. PubMed ID: 39153118 [TBL] [Abstract][Full Text] [Related]
8. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251 [TBL] [Abstract][Full Text] [Related]
9. Telogen effluvium after allergic contact dermatitis of the scalp. Tosti A; Piraccini BM; van Neste DJ Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 infection is a major cause of acute telogen effluvium. Sharquie KE; Jabbar RI Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470 [TBL] [Abstract][Full Text] [Related]
11. Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial. Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Pawitan JA; Liem IK; Kurniawati T; Ardelia A; Paramastri K Stem Cell Res Ther; 2023 Aug; 14(1):210. PubMed ID: 37605227 [TBL] [Abstract][Full Text] [Related]
12. Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation. Daly T; Daly K J Drugs Dermatol; 2018 Nov; 17(11):1236-1240. PubMed ID: 30500148 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of QR678 Neo Shome D; Kapoor R; Surana M; Vadera S; Shah R J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139 [TBL] [Abstract][Full Text] [Related]
14. Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell-Conditioned Medium. Narita K; Fukuoka H; Sekiyama T; Suga H; Harii K Dermatol Surg; 2020 Jun; 46(6):819-825. PubMed ID: 31490301 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial. Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study. Turlier V; Darde MS; Loustau J; Mengeaud V J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237 [TBL] [Abstract][Full Text] [Related]
17. Telogen Effluvium: A Review of the Literature. Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303 [TBL] [Abstract][Full Text] [Related]
18. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management. Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients. İbiş S; Aksoy Saraç G; Akdağ T Dermatol Pract Concept; 2022 Jul; 12(3):e2022151. PubMed ID: 36159144 [TBL] [Abstract][Full Text] [Related]
20. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia. Zufishan S; Haque Z; Nazar S; Afaq E; Aamir E; Rafique S J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S47-S50. PubMed ID: 38385471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]